Alteration of these regulatory mechanisms can modify molecular pathways and cellular processes, thus affecting phenotype, disease onset and possibly even disease outcome. In fact, genetic variations in the UTRs have been already implicated in several diseases such as melanoma, Alzheimer’s disease, multiple myeloma, fragile X syndrome, bipolar disorder, breast cancer and other pathologies.11
